Use Of Mitomycin C For Corneal-conjunctival Intraepithelial Neoplasia: Management Options - Case Reports [uso De Mitomicina C Em Neoplasia Intra-epitelial Córneo-conjuntival: Modalidades De Abordagem - Relato De Casos]

Three cases of corneal-conjunctival intraepithelial neoplasia treated differently with mitomycin C based on clinical presentation are reported. The selected patients were followed at the Department of Ophthalmology of the Casa de Saúde Santo Inácio. According to the clinical appearance of the lesions, 0.04% mitomycin C was employed in three different ways: 1) postoperative chemoablation; 2) preoperative chemoreduction; and 3) isolated chemoablation. Regression of the neoplastic lesion was observed in all cases with no recurrence detected during a follow-up time ranging from 18 to 29 months. Conjunctival hyperemia was the single side effect. The use of mitomycin C seems to be efficient and safe for the treatment of corneal-conjunctival intraepithelial neoplasia under several approaches.693407411Grossniklaus, H.E., Green, W.R., Luckenbach, M., Chan, C.C., Conjunctival lesions in adults. A clinical and histopathologic review (1987) Cornea, 6 (2), pp. 78-116Lee, G.A., Hirst, L.W., Ocular surface squamous neoplasia (1995) Surv Ophthalmol, 39 (6), pp. 429-450Eric, J.C., Campbell, R.J., Liesegang, T.J., Conjunctival and corneal intraepithelial and invasive neoplasia (1986) Ophthalmology, 93 (2), pp. 176-183Giaconi, J.A., Karp, C.L., Current treatment options for conjunctival and corneal intraepithelial neoplasia (2003) Ocul Surface, 2, pp. 66-73Newton, R., Ferlay, J., Reeves, G., Beral, V., Parldn, D.M., Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye (1996) Lancet, 347 (9013), pp. 1450-1451Lee, G.A., Williams, G., Hirst, L.W., Green, A.C., Risk factors in the development of ocular surface epithelial dysplasia (1994) Ophthalmology, 101 (2), pp. 360-364Smith, J.R., Kitchen, V.S., Botcherby, M., Hepburn, M., Wells, C., Gor, D., Is HIV infection associated with an increase in the prevalence of cervical neoplasia? (1993) Br J Obstet Gynaecol, 100 (2), pp. 149-153Vermund, S.H., Kelley, K.F., Klein, R.S., Feingold, A.R., Schreiber, K., Munk, G., High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection (1991) Am J Obstet Gynecol, 165 (2), pp. 392-400Tabin, G., Levin, S., Snibson, G., Loughnan, M., Taylor, H., Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia (1997) Ophthalmology, 104 (3), pp. 485-492. , Comment in: Ophthalmology. 1997;104(10):1531Wilson, M.W., Hungerford, J.L., George, S.M., Madreperla, S.A., Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia (1997) Am J Ophthalmol, 124 (3), pp. 303-311. , Comment in: Am J Ophthalmol. 1997;124(3):381-3Kemp, E.G., Harnett, A.N., Chatterjee, S., Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias (2002) Br J Ophthalmol, 86 (1), pp. 31-34Siganos, C.S., Kozobolis, V.P., Christodoulakis, E.V., The intraoperative use of mtomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation (2002) Cornea, 21 (1), pp. 12-16. , Erratum in: Cornea. 200322(2):189. Erratum in: Cornea. 2003;22(2):189. Comment in: Cornea. 2002;21 (8):840-1author reply 841-2Akpek, E.K., Ertoy, D., Kalayci, D., Hasiripi, H., Postoperative topical mitomycin C in conjunctival squamous cell neoplasia (1999) Cornea, 18 (1), pp. 59-62Heigle, T.J., Stulting, R.D., Palay, D.A., Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C (1997) Am J Ophthalmol, 124 (3), pp. 397-399. , Comment in: Am J Ophthalmol. 1997;124(3):381-3Shields, C.L., Naseripour, M., Shields, J.A., Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma (2002) Am J Ophthalmol, 133 (5), pp. 601-606. , Comment in: Am J Ophthalmol. 2003;135(1):122-3author reply 123-4Frucht-Pery, J., Sugar, J., Baum, J., Sutphin, J.E., Pe'er, J., Savir, H., Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: A multicenter experience (1997) Ophthalmology, 104 (12), pp. 2085-2093Ballalai, P.L., Gomes, J.A., Santos, M.S., Freitas, D., Erwenne, C.M., Rigueiro, M., Uso de mitomicina C tópico no tratamento da neoplasia intra-epitelial córneo-conjuntival e carcinoma espinocelular conjuntival - Resultados preliminares (2003) Afq Bras Oftalmol, 66 (5), pp. 559-562Shields, J.A., Shields, C.L., Premalignant and malignant tumors of the conjunctival epithelium (1999) Atlas of Eyelid and Conjunctival Tumors, Atlas of Intraocular Tumors and Atlas of Orbital Tumors, , Shields JA, Shields CL. Philadelphia: Wiliams & WilkinsDaniell, M., Maini, R., Tole, D., Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia (2002) Clin Experiment Ophthalmol, 30 (2), pp. 94-98Cartsburg, O., Kersten, A., Sundmacher, R., Nadjari, B., Pomjanski, N., Bocking, A., Treatment of 9 squamous epithelial carcinoma in situ leions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control) (2001) Klin Monatsbl Augenheilkd, 218 (6), pp. 429-434. , GermanFrucht-Pery, J., Rozenman, Y., Pe'er, J., Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma (2002) Ophthalmology, 109 (3), pp. 548-552Shields, C.L., Shields, J.A., Tumors of the conjunctiva and cornea (2004) Surv Ophthalmol, 49 (1), pp. 3-24Wilson, M.W., Czechonska, G., Finger, P.T., Rausen, A., Hooper, M.E., Haik, B.G., Chemotherapy for eye cancer (2001) Surv Ophthalmol, 45 (5), pp. 416-44